Reliably gripping and turning small parts

The extremely compact rotary gripper module EHMD is the ideal choice in many life science applications where small objects need to be gripped and turned in conf...

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”

It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...

Medical plastics insights at Röchling

An exclusive look behind the scenes.

Medicon Valley Alliance

Aurevia

Don't miss out on this unique opportunity

ZEISS QUALITY INNOVATION SUMMIT October 22 - 24 in Berlin.

Hjälpmedel saknas i ny lag om beredskap

Regeringens nya lagförslag om vårdens beredskap fokuserar på akuta insatser – men missar nästan helt hjälpmedel och rehabilitering. ”En stor brist”, säger Ida K...

Novo Nordisk buys drug candidate in billion dollar deal

The Danish pharmaceutical giant Novo Nordisk have made an agreement with KBP Biosciences to aqcuire the hypertension drug ocedurenone for up to 1.3 billion doll...

The investor: “The major common diseases are hot again”

She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...

Egetis läkemedel Emcitate lanserat i Tyskland

Från och med 1 maj finns den första och enda behandlingen för patienter som lider av MCT8-brist tillgänglig i Tyskland. Det bekräftar Egetis Therapeutics.

GSK acquires oncology research company

GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.

“We need to keep investing in research and innovation”

Jenni Nordborg has worked for just over four years to highlight life science in Sweden. Her mandate as national coordinator ends in December 2022. ““Life scienc...

MSD discontinues development of cancer drugs after trial failures

MSD suspends Phase 3 trials for two drug programs for different forms of cancer after trial failures.

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

The art of building a biologic drug

The first biosimilar from Xbrane Biopharma was launched earlier this year, and several more are under development at the company’s facility in Solna, Sweden. “W...

KI’s freezer fiasco investigated: A chain of failures

A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying...

Nanoparticles to help detect pulmonary disease

Nanoparticles behave in a certain way in the air. Using this knowledge, researchers at Lund University have developed a new measurement method for lung examinat...

Integrated solutions for liquid handling

Greater efficiency for manufacturers in laboratory automation and many other industries

Scanautomatic 8-10 oktober - Kom förbi med din utmaning, gå hem med en lösning!

Denna mässa får du inte missa! Vi kommer ha en monter på 90 kvm och visa upp vår bredd i sortimentet, vår kunskap och självklart vill vi snacka lösningar med di...

The pandemic caused a reshuffle among the world’s vaccine giants – here is the new top list

Fuelled by the pandemic, the power balance in the global vaccine market has completely changed in recent years, a survey from Fierce Pharma shows

Magnus Gisslén släpper fyra videoklipp med skarp kritik – här är del ett

”Det finns inte en enda läkare eller person med djupare medicinsk kompetens i Folkhälsomyndighetens ledningsgrupp”. Det säger Magnus Gisslén i det första i en s...

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...

600 million SEK for life science - "Should not be the country of moderation"

Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.